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Mediastinal liposarcoma (ML) is a rare mesenchymal tumor, accounting for less than 1% of mediastinal
tumors. They have a slow growth, so they may not give symptoms for a long time, until the tumor
produces compression of close structures. The treatment of choice is surgery, which can be combined
with chemo-radiotherapy. We present a case in which the diagnosis of a ML was made in a 30-year-old
woman with dyspnea and chest pain.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Liposarcomas are malignant tumors with a mesenchymal origin.
The most frequent locations are the lower limbs and retro-
peritoneum. Mediastinal liposarcoma (ML) is a rare entity, ac-
counting for less than 1% of mediastinal tumors, and 2% of
liposarcomas [1,2]. ML has been described in all mediastinal com-
partments, but it seems to have a certain predominance in the
posterior mediastinum [3].
Their growth is slow, so they may not give symptoms for a long
time. Symptoms usually appear when the tumor has already
reached a large size and produces compression of neighboring
structures. It has been described that they can initially originate as
lipomas, which eventually malignize [4].
The treatment of choice is surgery, which must be exhaustive in
order to achieve a complete resection, sinceML tend to be recurrent
[5].
The most important prognostic factors are size, degree of dif-
ferentiation, location and complete resection [6].2. Case presentation
We present the case of a 30-year-old woman who came to theez-Tena), fjlopezglez@gmail.
Ltd. This is an open access article uhospital emergency department in September 2015, referring a
week of progressive dyspnea, accompanied by sharp pain in left
hemithorax and chest tightness. She didn't refer other symptoms.
She had multiple food allergies, controlled by the Allergology
department, and allergic rhinitis and asthma that was treating with
terbutaline and antihistamines on demand. She has never had toxic
habits, and works as a graphic designer at a printing press.
Physical examination only highlighted an abolition of the ve-
sicular murmur and vocal vibrations in the left lung base.
The blood test performed in the emergency room was strictly
normal. In the chest X-ray, a large left paracardiac mass was
observed, which in the lateral projectionwas located in the anterior
mediastinum (Fig. 1). Thoracic echography revealed a paracardiac
mass of about 10 cm in diameter.
The patient was admitted to the Pneumology Service with the
suspicion of an anterior mediastinal tumor. During admission, a CT
scan of chest, abdomen and pelvis was performed, conﬁrming the
presence in the left anterior mediastinum of a 10  11 cm of
diameter tumor located to the left of the heart and in front of the
left lung. The lesion had an intimate contact with the adjacent
pericardium with effacement of the fat planes (Fig. 2). A CT-guided
needle biopsy was performed. The biopsy was informed as
compatible with a low grade myoﬁbroblastic tumor. During
admission, a PET-CT was performed, which showed that the mass
had a heterogeneousmetabolic behavior, with a SUVmax. of 4.83 g/
mL. The remaining structures showed no increase in glucose
metabolism (Fig. 3). Thoracic MRI was also performed, which
showed that the tumor had a broad contact with the pericardium,nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. The chest X-ray showed a big mass located in anterior mediastinum.
Fig. 2. The chest CT scan revealed a 10  11 cm mass located in the anterior medi-
astinum, to the left of the heart. The tumor had two components: a bigger part with an
intense peripheral contrast uptake and necrotic center, and a smaller part with pres-
ence of multiple calciﬁcations.
Fig. 3. The PET-CT revealed that the tumor had a heterogeneous metabolic behavior,
with a SUV max of 4.83 g/mL.
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With the diagnose of a low grade myoﬁbroblastic tumor, the
patient was referred to the Thoracic Surgery Service. A thor-
acoplasty was performed, dissecting the mass and part of the
pericardium where it was not possible to dissect. The main
complication was an intense bleeding which needed the trans-
fusion of 2 units of red blood cells. The resected piece was sub-
mitted to the Pathological Anatomy Service and analyzed by the
same team of the previous needle biopsy, which provided the
deﬁnitive diagnosis of a dedifferentiated liposarcoma with bone
metaplasia. The surgical margins were free of tumor and no
lymphatic or vascular invasion was identiﬁed. The chest X-ray two
months before surgery can be observed in Fig. 4.
After surgery, the patient was referred to the Medical Oncology
Service, who proposed her to start adjuvant chemotherapy treat-
ment with four cycles of ifosfamide-adriamycin. The possibility of
concomitant local radiotherapy was considered, but it was rejected
because of the high risk of toxicity and sequelae.
The chemotherapeutic treatment was administrated betweenDecember 2015 and April 2016. Onemonth later, a new PET-CT scan
was performed, which showed no increase in glycolic metabolism
at any level.
The patient currently follows periodic check-ups at the Medical
Oncology Service, performing chest CT every 6months. The last one
was performed in February 2017, and was strictly normal. Until
date, she has not developed a recurrence of the ML.3. Discussion
ML are very rare tumors. They account for less than 1% of
mediastinal tumors, and comprise approximately 2% of lip-
osarcomas [1,2]. A certain predominance has been observed in
males between the second and seventh decades of life [7,8]. They
are slow-growing tumors, which usually only produce symptoms
when they reach a large size, due to the compression of neigh-
boring mediastinal structures. The presence of superior vena cava
syndrome has been associated with early mortality [9,10].
The diagnosis of suspicion arises from CT images, in which a
large mass is usually observed, which combines fat densities, with
attenuations similar to other soft tissues [4,5,9]. The deﬁnitive
diagnosis is based on the anatomopathological study of the lesion.
In the case of our patient initially a diagnosis of low grade myoﬁ-
broblastic tumor was established, which was modiﬁed to a
Fig. 4. Chest X-ray performed two months after surgery.
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after analyzing the surgical specimen. Probably, due to the het-
erogeneous nature of these tumors, a single percutaneous biopsy is
not enough to establish a diagnosis of certainty.
The treatment of choice is resection surgery. A complete exci-
sion of the lesion should always be attempted [5,11]. Radiotherapy
seems to decrease recurrences, but has not been shown to have an
effect on survival. Chemotherapy is used in combination with
radiotherapy as a neoadjuvant treatment, as well as to prevent
recurrences in the postoperative period. The choice scheme is the
combination of ifosfamide with adriamycin [12]. The possibility of
an immunomodulatory and molecular therapy-based treatment is
being studied, but further studies are still needed to clarify its ef-
ﬁcacy [13,14]. Our patient received adjuvant chemotherapy with
ifosfamide-adriamycin to avoid recurrences, but, radiotherapy was
rejected because the risks were supposed to be greater than the
potential beneﬁts, although she is a young woman with no asso-
ciated comorbidities. Attending to the available bibliography, we
consider that our patient would have beneﬁted from the radio-
therapeutic treatment in order to decrease the risk of recurrences.
The most important prognostic factors are size, degree of dif-
ferentiation, location and complete resection. Due to the high
recurrence rate, patients should be monitored in the long term [5].
Our patient, after 1.5 years of follow-up, persists without data of
tumor recurrence. However, we must be cautious and keep the
medical checks over several years.
4. Conclusions
The mediastinal liposarcoma is a rare mesenchymal tumor,
usually diagnosed when it has reached a big size and produces
symptoms because of the compression of neighboring structures.
The ideal treatment is surgical resection, which can be combined
with chemo-radiotherapy to reduce the risk of recurrences, which
usually are frequent.
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